Skip to the rundown
GetYourBrief Biotech desk · October 2, 2026
Search

Biotech desk · drug development, clinical trials, approvals and life-science deals

Biotech news: the latest, Friday, October 2, 2026

On Friday, October 2, 2026 the Biotech desk recorded 1 news event, drawn from 2 outlet reports. That is 29% below the desk's 30-day average of 1.4 a day.

Friday, October 2, 2026

  1. 01

    Scandinavian trial finds no aspirin benefit after colorectal cancer liver metastases treatment

    2 outlets · first: Newswise Clinical trial

1 event homed on this desk, ordered by outlets. Source: the outlets' own reports, linked on each event. The full rundown for October 2, 2026, with key facts and every report.

Thursday, October 1, 2026

  1. 01

    Lenacapavir PrEP: 0 HIV Cases in 2,000+ Woman Trial as Generics Loom

    2 outlets · first: Al Jazeera Clinical trial

  2. 02

    Court upholds patent claims in United Therapeutics-Liquidia dispute

    2 outlets · first: 247wallst.com Pharma

  3. 03

    OS Therapies Adds 2 Execs to Drive 3-Market Herlystic Launch

    2 outlets · first: finanznachrichten.de Fda approval

3 events homed on this desk, ordered by outlets. Source: the outlets' own reports, linked on each event. The full rundown for October 1, 2026, with key facts and every report.

Tuesday, September 29, 2026

  1. 01

    Unicycive resubmits NDA for oxylanthanum carbonate

    2 outlets · first: manilatimes.net Fda approval Mostly press releases

  2. 02

    Coverage recordthehindu.com: “U.S. waives tariffs on certain speciality drugs from 20 countries, including India”

    2 outlets · first: The Hindu Pharma

2 events homed on this desk, ordered by outlets. Source: the outlets' own reports, linked on each event. The full rundown for September 29, 2026, with key facts and every report.

Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).